|
End-of-day quote
Shenzhen S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 6.190 CNY | +4.56% |
|
-7.34% | -1.28% |
| Market Cap | 2.88B 428M 367M 344M 314M 592M 40.8B 598M 4.05B 1.58B 20.58B 1.61B 1.57B 68.17B | P/E 2024 |
17.7x | P/E 2025 | 29.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.58B 532M 456M 427M 390M 737M 50.73B 744M 5.04B 1.96B 25.6B 2B 1.95B 84.77B | EV / Sales 2024 |
0.84x | EV / Sales 2025 | 0.94x |
| Free-Float |
64.76% | Yield 2024 |
1.63% | Yield 2025 | 1.59% |
| 1 day | +4.56% | ||
| 1 week | -7.34% | ||
| Current month | +13.37% | ||
| 1 month | +19.04% | ||
| 3 months | +4.03% | ||
| 6 months | -7.89% | ||
| Current year | -1.28% |
| 1 week | 5.86 |  | 6.73 |
| 1 month | 5.18 | | 7.35 |
| Current year | 4.95 | | 7.35 |
| 1 year | 4.95 | | 7.35 |
| 3 years | 4.26 | | 8.08 |
| 5 years | 4.26 | | 12.13 |
| 10 years | 3.4 | | 12.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tian Le Ru
CEO | Chief Executive Officer | 41 | 2022-07-06 |
Jun Li
DFI | Director of Finance/CFO | 49 | 2017-03-15 |
Qun Shan Zhang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Zhen Hong Lu
BRD | Director/Board Member | 51 | 2016-03-27 |
Tian Le Ru
BRD | Director/Board Member | 41 | 2022-07-06 |
Jin Chao Duan
BRD | Director/Board Member | 43 | 2022-07-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.56% | -7.34% | -12.20% | -2.63% | 428M | |
| -1.06% | +0.65% | +77.42% | +122.82% | 1,100B | |
| +0.53% | +0.75% | +53.10% | +64.29% | 658B | |
| +0.48% | +2.65% | +28.06% | +81.19% | 470B | |
| +0.92% | +3.57% | +43.82% | +44.21% | 372B | |
| +1.25% | +2.21% | +26.77% | +43.05% | 304B | |
| +3.02% | +5.68% | +4.24% | +17.04% | 264B | |
| -0.36% | +3.99% | +53.31% | +72.49% | 239B | |
| +2.86% | +3.86% | -16.20% | -51.83% | 213B | |
| +1.38% | +3.72% | +30.33% | +93.56% | 184B | |
| Average | +1.36% | +2.07% | +28.87% | +48.42% | 380.33B | |
| Weighted average by Cap. | +0.45% | +2.21% | +45.67% | +71.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.28B 637M 546M 512M 468M 882M 60.77B 891M 6.04B 2.35B 30.66B 2.39B 2.34B 102B | 3.86B 574M 492M 461M 421M 795M 54.72B 802M 5.44B 2.12B 27.61B 2.16B 2.11B 91.43B |
| Net income | 161M 23.93M 20.5M 19.21M 17.55M 33.12M 2.28B 33.45M 227M 88.23M 1.15B 89.85M 87.89M 3.81B | 99.42M 14.79M 12.67M 11.88M 10.85M 20.47M 1.41B 20.68M 140M 54.54M 711M 55.54M 54.33M 2.36B |
| Net Debt | 734M 109M 93.56M 87.67M 80.08M 151M 10.41B 153M 1.03B 403M 5.25B 410M 401M 17.39B | 701M 104M 89.31M 83.68M 76.44M 144M 9.94B 146M 987M 384M 5.01B 391M 383M 16.6B |
Employees
4,278
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | CN¥6.190 | +4.56% | 31,327,099 |
| 26-08-24 | CN¥5.920 | -2.47% | 25,857,783 |
| 26-08-21 | CN¥6.070 | -2.88% | 48,747,257 |
| 26-08-20 | CN¥6.250 | -5.45% | 81,612,457 |
| 26-08-19 | CN¥6.610 | -1.05% | 106,755,912 |
- Stock Market
- Stocks
- 000153 Stock
Select your edition
All financial news and data tailored to specific country editions
